North American Partners in Anesthesia provides critical services to AdvantageCare Physicians patients in East New York, Brooklyn

NEXT STORY
Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation
PREV STORY
Worldwide IVD Test Procedure Volumes Report, 2019-2024: Data on Point-of-Care (POC), Clinical Chemistry, Molecular Testing, Hematology, Coagulation Testing, Microbiology, and More Procedures
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

North American Partners in Anesthesia provides critical services to AdvantageCare Physicians patients in East New York, Brooklyn

NEXT STORY
Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation
PREV STORY
Worldwide IVD Test Procedure Volumes Report, 2019-2024: Data on Point-of-Care (POC), Clinical Chemistry, Molecular Testing, Hematology, Coagulation Testing, Microbiology, and More Procedures
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oasmia has completed a directed share issue of approximately 165 MSEK

author_avatar
NASDAQ Market News

Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies

BERKELEY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today ...

author_avatar
NASDAQ Market News

Coherus BioSciences to Report Second Quarter 2018 Financial Results on August 8th

REDWOOD CITY, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News